Citation Impact

Citing Papers

SuFEx-enabled, agnostic discovery of covalent inhibitors of human neutrophil elastase
2019 StandoutNobel
Dendritic Cells Express Multiple Chemokine Receptors Used as Coreceptors for HIV Entry
1998 StandoutNobel
Eosinophil Chemotactic Chemokines (Eotaxin, Eotaxin-2, RANTES, Monocyte Chemoattractant Protein-3 (MCP-3), and MCP-4), and C-C Chemokine Receptor 3 Expression in Bronchial Biopsies from Atopic and Nonatopic (Intrinsic) Asthmatics
1999
Functional diversity of helper T lymphocytes
1996 StandoutNature
Airways inflammationin asthma and chronic bronchitis
1996
Different cytokine patterns in bronchial biopsies in asthma and chronic bronchitis
1996
Increased number of activated lymphocytes in human lung following swine dust inhalation
1997
Expression of IL-12 and IL-13 mRNA in asthma and their modulation in response to steroid therapy.
1997
Ozone-induced Airway Inflammation in Human Subjects as Determined by Airway Lavage and Biopsy
1993
Remodeling of asthmatic airways by glucocorticosteroids
1996
Atopic Dermatitis
2008 Standout
Th2 cells and GATA-3 in asthma: new insights into the regulation of airway inflammation
1999
Chemokines and allergic disease
1999
Bronchial mucosal expression of the genes encoding chemokines RANTES and MCP-3 in symptomatic atopic and nonatopic asthmatics: relationship to the eosinophil-active cytokines interleukin (IL)-5, granulocyte macrophage-colony-stimulating factor, and IL-3.
1997
Lumacaftor–Ivacaftor in Patients with Cystic Fibrosis Homozygous for Phe508delCFTR
2015 Standout
T-cell cytokine profile evaluated at the single cell level in BAL and blood in allergic asthma.
1996
The β-Chemokine Receptors CCR3 and CCR5 Facilitate Infection by Primary HIV-1 Isolates
1996 Standout
The Orphan Nuclear Receptor RORγt Directs the Differentiation Program of Proinflammatory IL-17+ T Helper Cells
2006 Standout
ICOS co-stimulatory receptor is essential for T-cell activation and function
2001 StandoutNatureNobel
Sputum analysis, bronchial hyperresponsiveness, and airway function in asthma: Results of a factor analysis
1999
Early intervention with budesonide in mild persistent asthma: a randomised, double-blind trial
2003
Atopic dermatitis
2003 Standout
Effect of Dexamethasone and Cyclosporin A on Allergen-induced Airway Hyperresponsiveness and Inflammatory Cell Responses in Sensitized Brown-Norway Rats
1992
Early identification of interleukin-16 (lymphocyte chemoattractant factor) and macrophage inflammatory protein 1 alpha (MIP1 alpha) in bronchoalveolar lavage fluid of antigen-challenged asthmatics.
1995
Cystic fibrosis
2016 Standout
The Effect of Infections on Susceptibility to Autoimmune and Allergic Diseases
2002 Standout
The distribution of eosinophils and lymphocytes in the large and small airways of asthmatics
1997
Allergic and nonallergic forms of atopic diseases
2003
Glucocortidoid sensitivity assessed in peripheral blood cells do not correlate with the feedback sensitivity of the hypothalamo-pituitary adrenal AXIS
2002
Nuclear Factor-κB — A Pivotal Transcription Factor in Chronic Inflammatory Diseases
1997 Standout
Eosinophil function in health and disease
1995
Chemokines — Chemotactic Cytokines That Mediate Inflammation
1998 Standout
Mediator and cytokine mechanisms in asthma.
1993
Nitric Oxide and Airway Disease
1995
Glucocorticosteroid inhibition of cytokine production: Relevance to antiallergic actions
1996
Distinguishing severe asthma phenotypes
2004
Clinical trials in cystic fibrosis
2007
Results of a Home-Based Environmental Intervention among Urban Children with Asthma
2004 Standout
Interleukin-17 in sputum correlates with airway hyperresponsiveness to methacholine
2003
A role for the C3a anaphylatoxin receptor in the effector phase of asthma
2000 Nature
Cystic Fibrosis Pulmonary Guidelines
2007
Dendritic cells are associated with augmentation of antigen sensitization by influenza A virus infection in mice
2000
Asthma
1992
Effects of inhaled budesonide on allergen-induced airway responses and airway inflammation.
1996
Activated T-Lymphocytes and Macrophages in Bronchial Mucosa of Subjects with Chronic Bronchitis
1993
Mepolizumab and Exacerbations of Refractory Eosinophilic Asthma
2009 Standout
CD4 T-Lymphocyte Activation in Asthma Is Accompanied by Increased Serum Concentrations of Interleukin-5: Effect of Glucocorticoid Therapy
1993
Cytokines in asthma
1999
Enhanced expression of eotaxin and CCR3 mRNA and protein in atopic asthma. Association with airway hyperresponsiveness and predominant co‐localization of eotaxin mRNA to bronchial epithelial and endothelial cells
1997
Prednisone-dependent asthma: inflammatory indices in induced sputum
1999
Induction of nitric oxide synthase in asthma
1993
Granulocyte-macrophage colony-stimulating factor, eosinophils and eosinophil cationic protein in subjects with and without mild, stable, atopic asthma
1994
The role of female sex hormones in the development and severity of allergic and non‐allergic asthma
2009
Repeated daily exposure to 2 ppm nitrogen dioxide upregulates the expression of IL-5, IL-10, IL-13, and ICAM-1 in the bronchial epithelium of healthy human airways
2003
Glucocorticoid receptor gene polymorphisms and glucocorticoid sensitivity of subdermal blood vessels and leukocytes
2008
Pirfenidone in patients with idiopathic pulmonary fibrosis (CAPACITY): two randomised trials
2011 Standout
Identification of T lymphocytes, Macrophages, and Activated Eosinophils in the Bronchial Mucosa in Intrinsic Asthma: Relationship to Symptoms and Bronchial Responsiveness
1992
High-affinity IgE receptor (FcepsilonRI)-bearing cells in bronchial biopsies from atopic and nonatopic asthma.
1996
Airway Mucosal Inflammation Even in Patients with Newly Diagnosed Asthma
1993
Eosinophilic and neutrophilic inflammation in asthma, chronic bronchitis, and chronic obstructive pulmonary disease
1993
Asthma: defining of the persistent adult phenotypes
2006
Review of the Molecular and Cellular Mechanisms of Action of Glucocorticoids for Use in Asthma
2002
Asthma
2017 Standout
Expression of mRNA for interleukin-5 in mucosal bronchial biopsies from asthma.
1991
A CFTR Potentiator in Patients with Cystic Fibrosis and the G551D Mutation
2011 Standout
Molecular pathology of allergic disease
2000
Salivary cortisol as a biomarker in stress research
2008 Standout
Interleukin-5 mRNA in Mucosal Bronchial Biopsies from Asthmatic Subjects
1991
Efficacy and safety of lebrikizumab in patients with uncontrolled asthma (LAVOLTA I and LAVOLTA II): replicate, phase 3, randomised, double-blind, placebo-controlled trials
2016
Interleukin-17 and Type 17 Helper T Cells
2009 Standout
The role of lymphocytes in allergic disease
2000
Glucocorticoids and the Th1/Th2 Balance
2004
Cyclosporine A inhibits airway reactivity and remodeling after chronic antigen challenge in cats.
1996
The development of allergic inflammation
2008 StandoutNature
Inflammation and airway reactivity in asthma
1992
Airway epithelial cell expression of interleukin-6 in transgenic mice. Uncoupling of airway inflammation and bronchial hyperreactivity.
1994
Induction of corticosteroid insensitivity in human PBMCs by microbial superantigens
2000
Myofibroblast involvement in the allergen-induced late response in mild atopic asthma.
1997
Asthma
2001 Standout
The immunology of asthma
2014
Effect of Aerosolized Recombinant Human DNase on Exacerbations of Respiratory Symptoms and on Pulmonary Function in Patients with Cystic Fibrosis
1994 Standout
Effects of Treatment on Airway Inflammation and Thickening of Basement Membrane Reticular Collagen in Asthma: A Quantitative Light and Electron Microscopic Study
1992
Activated T cells and eosinophilia in bronchoalveolar lavages from subjects with asthma correlated with disease severity
1991
Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma
2014 Standout
Gene expression of the GATA-3 transcription factor is increased in atopic asthma
1999
Cystic Fibrosis Pulmonary Guidelines
2013
Asthma phenotypes: the evolution from clinical to molecular approaches
2012 Standout
Pulmonary expression of interleukin-13 causes inflammation, mucus hypersecretion, subepithelial fibrosis, physiologic abnormalities, and eotaxin production
1999 Standout
Activated T-lymphocytes and eosinophils in the bronchial mucosa in isocyanate-induced asthma
1992
Remodeling in Asthma
2009
Short-term efficacy of ultrasonically nebulized hypertonic saline in cystic fibrosis
1996
Phenotype of cells expressing mRNA for TH2-type (interleukin 4 and interleukin 5) and TH1-type (interleukin 2 and interferon gamma) cytokines in bronchoalveolar lavage and bronchial biopsies from atopic asthmatic and normal control subjects.
1995
The effects of glucocorticoids on human eosinophils
1994
Effects of steroid therapy on inflammatory cell subtypes in asthma
2009
Interleukin-4, -5, and -6 and tumor necrosis factor-alpha in normal and asthmatic airways: evidence for the human mast cell as a source of these cytokines.
1994
Time course of changes in adenosine 5′-monophosphate airway responsiveness with inhaled heparin in allergic asthma
1997
Mepolizumab for severe eosinophilic asthma (DREAM): a multicentre, double-blind, placebo-controlled trial
2012 Standout
Airway Mucus Function and Dysfunction
2010 Standout
Activation of CD4+ T cells, increased TH2-type cytokine mRNA expression, and eosinophil recruitment in bronchoalveolar lavage after allergen inhalation challenge in patients with atopic asthma
1993
Intraepithelial Mast Cells in Allergic and Nonallergic Asthma: Assessment Using Bronchial Brushings
1993
Airway inflammation after removal from the causal agent in occupational asthma due to high and low molecular weight agents
1994
Outdoor air pollution and asthma
2014 Standout
Inflammation in bronchial biopsies of subjects with chronic bronchitis: inverse relationship of CD8+ T lymphocytes with FEV1.
1997
Peripheral blood CD4 but not CD8 t-lymphocytes in patients with exacerbation of asthma transcribe and translate messenger RNA encoding cytokines which prolong eosinophil survival in the context of a Th2-type pattern: effect of glucocorticoid therapy.
1995
The Nature of Small-Airway Obstruction in Chronic Obstructive Pulmonary Disease
2004 Standout
Increased sputum and bronchial biopsy IL-13 expression in severe asthma
2008
Eosinophils: Biology and Role in Disease
1995
Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity
2010 StandoutNature
Immunological Aspects of Allergic Asthma
1994
Inhibitory Effect of the TRFK-5 Anti-IL-5 Antibody in a Guinea Pig Model of Asthma
1993
Oligonucleotide therapy of allergic asthma☆☆☆
1999
Eosinophil recruitment to the lung in a murine model of allergic inflammation. The role of T cells, chemokines, and adhesion receptors.
1996
Comparison of inhaled mannitol, daily rhDNase and a combination of both in children with cystic fibrosis: a randomised trial
2009
Expression of endothelial and leukocyte adhesion molecules intercellular adhesion molecule-1, E-selectin, and vascular cell adhesion molecule-1 in the bronchial mucosa in steady-state and allergen-induced asthma
1993
Modulation by interleukin-4 of cytokine release from mononuclear phagocytes in asthma
1994
Allergen exposure induces the activation of allergen‐specific Th2 cells in the airway mucosa of patients with allergic respiratory disorders
1993
Exploring the full spectrum of macrophage activation
2008 Standout
Analysis of induced sputum in adults with asthma: identification of subgroup with isolated sputum neutrophilia and poor response to inhaled corticosteroids
2002
The Structure of Large and Small Airways in Nonfatal and Fatal Asthma
1993
Increased interleukin-10 messenger RNA expression in atopic allergy and asthma.
1996
The potential role of tumour necrosis factor a in asthma
1993
T-helper Type 2–driven Inflammation Defines Major Subphenotypes of Asthma
2009
Effects of an interleukin-5 blocking monoclonal antibody on eosinophils, airway hyper-responsìveness, and the late asthmatic response
2000 Standout
Hypertonic Induction of Aquaporin-5 Expression through an ERK-dependent Pathway
2000 StandoutNobel
β-Arrestin-2 regulates the development of allergic asthma
2003 StandoutNobel
Predominant TH2-like Bronchoalveolar T-Lymphocyte Population in Atopic Asthma
1992 Standout
Relationships among numbers of bronchoalveolar lavage cells expressing messenger ribonucleic acid for cytokines, asthma symptoms, and airway methacholine responsiveness in atopic asthma
1993
Pathological features and inhaled corticosteroid response of eosinophilic and non-eosinophilic asthma
2007
The role of T lymphocytes in the pathogenesis of asthma
2003
Inhaled beclomethasone dipropionate downregulates airway lymphocyte activation in atopic asthma.
1994
Mast Cell and Basophil Number in the Airway Correlate with the Bronchial Responsiveness of Asthmatics
1995
RAMPs regulate the transport and ligand specificity of the calcitonin-receptor-like receptor
1998 StandoutNature
Asthma
2000 Standout
Airway Inflammation in Mild Intermittent and in Persistent Asthma
1998
Mechanisms of Eosinophil Recruitment
1993
Pirfenidone Modulates Airway Responsiveness, Inflammation, and Remodeling after Repeated Challenge
2006
Effect of Inhaled Interleukin-5 on Airway Hyperreactivity and Eosinophilia in Asthmatics
1998
Inflammation and Airway Function in Asthma
1998
Eosinophil's Role Remains Uncertain as Anti–Interleukin-5 only Partially Depletes Numbers in Asthmatic Airway
2003
Eosinophil-associated TGF- β 1 mRNA Expression and Airways Fibrosis in Bronchial Asthma
1997
Cytokines as Mediators of Chronic Asthma
1994
Glucocorticoid Receptor Isoforms α and β in in Vitro Cytokine-induced Glucocorticoid Insensitivity
2004
Evidence That Severe Asthma Can Be Divided Pathologically into Two Inflammatory Subtypes with Distinct Physiologic and Clinical Characteristics
1999
Evidence of Airway Inflammation and Remodeling in Ski Athletes with and without Bronchial Hyperresponsiveness to Methacholine
2000
Mechanisms of persistent airway inflammation in asthma. A role for T cells and T-cell products.
1995
Dissociation between Airway Inflammation and Airway Hyperresponsiveness in Allergic Asthma
1998
Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease
2012 Standout
Release of RANTES, MIP-1 α , and MCP-1 into Asthmatic Airways Following Endobronchial Allergen Challenge
1997
Relationship between IL-4 and IL-5 mRNA Expression and Disease Severity in Atopic Asthma
1997
Interleukin-4 Alters Epithelial Cell Differentiation and Surfactant Homeostasis in the Postnatal Mouse Lung
1997
Effect of cyclosporin A on the allergen-induced late asthmatic reaction
1997
The effect of inhaled sodium cromoglycate on cellular infiltration into the bronchial mucosa and the expression of adhesion molecules in asthmatics
1997
Activation of A3 adenosine receptors on human eosinophils elevates intracellular calcium
1996 StandoutNobel
Allergen-induced bronchial hyperreactivity and eosinophilic inflammation occur in the absence of IgE in a mouse model of asthma
1997
Mouse Eotaxin Expression Parallels Eosinophil Accumulation during Lung Allergic Inflammation but It Is Not Restricted to a Th2-Type Response
1996
An Essential Role of Mast Cells in the Development of Airway Hyperresponsiveness in a Murine Asthma Model
2000
Requirement for IL-13 Independently of IL-4 in Experimental Asthma
1998 StandoutScience
Immunoreactivity for interleukin 3 and 5 and granulocyte/macrophage colony-stimulating factor of intestinal mucosa in bronchial asthma.
1995
Increased numbers of dendritic cells in the bronchial mucosa of atopic asthmatic patients: downregulation by inhaled corticosteroids
1996
Anti-inflammatory effects of inhaled beclomethasone dipropionate in nonatopic asthmatics
1996
Interleukin 4, but not interleukin 5 or eosinophils, is required in a murine model of acute airway hyperreactivity.
1996
Activated memory T helper cells in bronchoalveolar lavage fluid from patients with atopic asthma: relation to asthma symptoms, lung function, and bronchial responsiveness.
1993
Molecular cloning and characterization of a human eotaxin receptor expressed selectively on eosinophils.
1996
A Novel T Cell-Regulated Mechanism Modulating Allergen-Induced Airways Hyperreactivity in BALB/c Mice Independently of IL-4 and IL-5
1998
Interleukin 12 inhibits antigen-induced airway hyperresponsiveness, inflammation, and Th2 cytokine expression in mice.
1995
T cell-dependent regulation of eotaxin in antigen-induced pulmonary eosinophila.
1996
Antiinflammatory Action of Glucocorticoids — New Mechanisms for Old Drugs
2005 Standout
Interleukin 5 deficiency abolishes eosinophilia, airways hyperreactivity, and lung damage in a mouse asthma model.
1996 Standout
The Coordinated Action of CC Chemokines in the Lung Orchestrates Allergic Inflammation and Airway Hyperresponsiveness
1998
Expression of Interleukin 9 in the Lungs of  Transgenic Mice Causes Airway Inflammation, Mast Cell Hyperplasia, and Bronchial Hyperresponsiveness
1998
β-Arrestin-2 regulates the development of allergic asthma
2003 StandoutNobel
Airway eosinophilia and expression of interleukin‐5 protein in asthma and in exacerbations of chronic bronchitis
1996
Pathology of asthma
1992
Eotaxin: a potent eosinophil chemoattractant cytokine detected in a guinea pig model of allergic airways inflammation.
1994
Stenotrophomonas maltophilia: an Emerging Global Opportunistic Pathogen
2012 Standout
Interleukin-13: Central Mediator of Allergic Asthma
1998 StandoutScience
Influenza Virus–induced Dendritic Cell Maturation Is Associated with the Induction of Strong T Cell Immunity to a Coadministered, Normally Nonimmunogenic Protein
2003 StandoutNobel
Critical Role for IL-13 in the Development of Allergen-Induced Airway Hyperreactivity
2001
Induction of Airway Mucus Production By T Helper 2 (Th2) Cells: A Critical Role For Interleukin 4 In Cell Recruitment But Not Mucus Production
1997
The late asthmatic response is associated with baseline allergen‐specific proliferative responsiveness of peripheral T lymphocytes in vitro and serum interleukin‐5
1999
Relationship between the inflammatory infiltrate in bronchial biopsy specimens and clinical severity of asthma in patients treated with inhaled steroids.
1996
Bronchial biopsies and airway inflammation
1996
Cell matrix interactions in asthma
1997
Airway and lung elastic fibre is not reduced in asthma nor in asthmatics following corticosteroid treatment
1995
Genetic Susceptibility to Asthma — Bronchial Hyperresponsiveness Coinherited with a Major Gene for Atopy
1995
Effect of natural allergen exposure during the grass pollen season on airways inflammatory cells and asthma symptoms.
1996
Is there a unifying hypothesis for exercise-induced asthma?
1984
IMMUNOLOGIC BASIS OF ANTIGEN-INDUCED AIRWAY HYPERRESPONSIVENESS
1999

Works of B Assoufi being referenced

The effect of dexamethasone, cyclosporine, and rapamycin on T-lymphocyte proliferation in vitro: Comparison of cells from patients with glucocorticoid-sensitive and glucocorticoid-resistant chronic asthma
1994
Glucocorticoid resistant asthma: T-lymphocyte steroid metabolism and sensitivity to glucocorticoids and immunosuppressive agents
1996
Prednisolone Treatment in Asthma Is Associated with Modulation of Bronchoalveolar Lavage Cell Interleukin-4, Interleukin-5, and Interferon-γ Cytokine Gene Expression
1993
Increased expression of mRNA encoding RANTES and MCP-3 in the bronchial mucosa in atopic asthma
1996
Elevated expression of messenger ribonucleic acid encoding IL-13 in the bronchial mucosa of atopic and nonatopic subjects with asthma
1997
Secretion of the eosinophil‐active cytokines interleukin‐5, granulocyte/macrophage colonystimulating factor and interleukin‐3 by bronchoalveolar lavage CD4+ and CD8+ T cell lines in atopics asthmatics, and atopic and nonatopic controls
1995
Identification of Activated T Lymphocytes and Eosinophils in Bronchial Biopsies in Stable Atopic Asthma
1990
Human eosinophils express messenger RNA encoding RANTES and store and release biologically active RANTES protein
1996
IL-4 and IL-5 mRNA and protein in bronchial biopsies from patients with atopic and nonatopic asthma: evidence against "intrinsic" asthma being a distinct immunopathologic entity.
1996
Efficacy and safety of short-term administration of aerosolised recombinant human DNase I in adults with stable stage cystic fibrosis
1993
Eosinophils, T-lymphocytes, mast cells, neutrophils, and macrophages in bronchial biopsy specimens from atopic subjects with asthma: Comparison with biopsy specimens from atopic subjects without asthma and normal control subjects and relationship to bronchial hyperresponsiveness
1991
Prednisolone treatment in asthma. Reduction in the numbers of eosinophils, T cells, tryptase-only positive mast cells, and modulation of IL-4, IL-5, and interferon-gamma cytokine gene expression within the bronchial mucosa.
1996
Regular three monthly oral ciprofloxacin in adult cystic fibrosis patients infected with Pseudomonas aeruginosa
1993
Eosinophil cationic protein(ECP) and eosinophil protein X (EXP) concentrations in serum and bronchial lavage fluid in asthma. effect of prednisolone treatment.
1995
Direct recordings of the temperatures in the tracheobronchial tree in normal man.
1982
294 Eosinophils, T-lymphocytes, mast cells, neutrophils and macrophages in bronchial biopsies from atopic asthmatics: Comparison with atopic non-asthma and relationship to bronchial hyperresponsiveness
1991
Safety of fibreoptic bronchoscopy in asthmatic and control subjects and effect on asthma control over two weeks.
1996
THE LINK BETWEEN EXERCISE, RESPIRATORY HEAT EXCHANGE, AND THE MAST CELL IN BRONCHIAL ASTHMA
1983
Rankless by CCL
2026